Case Reports

Lorlatinib-induced remission in refractory acute myeloid leukemia with an anaplastic lymphoma kinase fusion

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
Division of Gastroenterology and Hepatology, New York University Langone Health System, New York, New York
Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
Haematologica Early view May 28, 2026 https://doi.org/10.3324/haematol.2026.300893